Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allosteric adenosine modulation to reduce allodynia.

H L Pan1, Z Xu, E Leung

  • 1Department of Anesthesiology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1009, USA.

Anesthesiology
|August 17, 2001
PubMed
Summary

Positive allosteric modulation of adenosine receptors with T62 effectively reduced hypersensitivity in neuropathic pain models. This approach enhances endogenous adenosine signaling, offering a potential strategy for chronic pain management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Profiling unmet post-acute care needs of an inpatient population in Hong Kong: can real-world data and machine learning algorithms bring precision to tertiary prevention in the community?

Hong Kong medical journal = Xianggang yi xue za zhi·2025
Same author

Toward a better understanding of barriers to wayfinding technology use for people with disabilities.

Assistive technology : the official journal of RESNA·2024
Same author

The Ideal Physical Therapist from the Perspective of Individuals With Limb Loss.

Canadian prosthetics & orthotics journal·2024
Same author

Data-driven service model to profile healthcare needs and optimise the operation of community-based care: A multi-source data analysis using predictive artificial intelligence.

Hong Kong medical journal = Xianggang yi xue za zhi·2023
Same author

High-dimensional machine learning to predict hospital readmission among older people with chronic kidney disease: abridged secondary publication.

Hong Kong medical journal = Xianggang yi xue za zhi·2023
Same author

Clinical Outcomes of Radiotherapy in Vaginal and Vulvar Melanoma: A High-volume Centre's Experience With a Rare Disease.

Clinical oncology (Royal College of Radiologists (Great Britain))·2022

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pain Research

Background:

  • Adenosine and its agonists alleviate hypersensitivity in chronic pain models.
  • Inhibitors of adenosine metabolism suggest tonic spinal adenosine release in pain states.
  • Positive allosteric modulators (PAMs) offer an alternative to direct agonists for enhancing endogenous ligand effects.

Purpose of the Study:

  • To investigate the efficacy of T62, a positive allosteric modulator of adenosine receptors, in reducing hypersensitivity in a rat model of neuropathic pain.
  • To explore the mechanism of action, including the involvement of spinal adenosine and A1 adenosine receptors.

Main Methods:

  • Rats with mechanical hypersensitivity induced by spinal nerve ligation were treated with intrathecal adenosine, T62, or a combination.

Related Experiment Videos

  • Systemic administration of T62 was also evaluated.
  • The role of A1 adenosine receptors was assessed using a specific antagonist (8-cyclopentyl-1,3-dipropylxanthine).

    • Main Results:

    • Both adenosine and T62 significantly reduced hypersensitivity.
    • T62 demonstrated additive effects when combined with adenosine.
    • Systemic T62 also reduced hypersensitivity, and this effect was blocked by intrathecal A1 receptor antagonist administration.

    Conclusions:

    • Ongoing spinal release of antiallodynic adenosine is suggested in this neuropathic pain model.
    • Positive allosteric modulation of adenosine receptors, specifically via A1 receptors, reduces hypersensitivity through a spinal mechanism.
    • Further research is needed to assess the clinical feasibility of adenosine receptor PAMs for chronic pain treatment.